Gene: RPP25
Official Full Name: ribonuclease P/MRP subunit p25provided by HGNC
Gene Summary: Enables ribonuclease P RNA binding activity. Contributes to ribonuclease P activity. Involved in tRNA 5'-leader removal. Located in centriolar satellite and nucleoplasm. Part of multimeric ribonuclease P complex and ribonuclease MRP complex. Biomarker of autistic disorder. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14429 | RPP25 Knockout cell line (HeLa) | Human | RPP25 | 1:3~1:6 | Negative | Online Inquiry |
KO14430 | RPP25 Knockout cell line (HCT 116) | Human | RPP25 | 1:2~1:4 | Negative | Online Inquiry |
KO14431 | RPP25 Knockout cell line (HEK293) | Human | RPP25 | 1:3~1:6 | Negative | Online Inquiry |
KO14432 | RPP25 Knockout cell line (A549) | Human | RPP25 | 1:3~1:4 | Negative | Online Inquiry |
RPP25 Gene Knockout Cell Lines are genetically engineered cellular models designed to elucidate the role of the Ribonuclease P Protein Subunit 25 (RPP25) in various biological processes. These cell lines are characterized by the targeted disruption of the RPP25 gene, enabling researchers to investigate its function and implications in cellular mechanisms, particularly those related to RNA processing and maturation. By utilizing CRISPR/Cas9 technology, we ensure precise genetic modifications, facilitating robust studies on the impact of RPP25 absence on cellular physiology.
The primary function of these knockout cell lines lies in their capacity to provide insight into the molecular pathways associated with RPP25. The absence of RPP25 allows researchers to assess the resulting changes in ribonucleoprotein complex formation and RNA metabolism, thus expanding our understanding of gene expression regulation. In addition, these cell lines serve as critical tools in exploring the implications of RPP25 in disease models, such as cancer and autoimmune disorders, where dysregulated RNA processing can lead to aberrant cellular behavior.
Scientific importance is evident in both research and clinical applications. For instance, RPP25 knockout models can assist in drug development by providing information on potential therapeutic targets. Additionally, these cell lines may enable the validation of biomarkers for pathologies associated with RNA processing defects, offering clinicians novel avenues for diagnosis and treatment strategies.
What distinguishes RPP25 Gene Knockout Cell Lines from existing alternatives is our commitment to high-quality biological reagents: our cell lines are rigorously validated for stability, specificity, and reproducibility. This ensures that researchers can achieve consistent results, which are paramount in advancing scientific knowledge.
In sum, these knockout cell lines are invaluable assets for researchers and clinicians alike, offering the possibility to uncover innovative insights into gene function and its role in human health. With extensive expertise in molecular biology and genetic engineering, our company is dedicated to providing premium biological products that empower the scientific community in their quest for discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.